|
|
Homeopathic suppositories applicable for treating gynaecological and urological diseases, based on natural producers and containing cacao butter, wax, highly mineralised mud of West Siberia lakes, anhydrous lanolin, aloe extract, white cedar oil in certain proportions. |
|
|
Method of treating of planocellular intraepithelial lesions of cervix of uterus Vaginal suppositories "Cervicon-DIM", containing diindolylmethane, are applied. The medication is applied for not less than 6 months in dosage 200 mg/day of diindolylmethane. The claimed method ensures durative anti-recurrence effect for not less than a year after the completion of the therapy, as well as stimulates the immune system, including general and local immunity of the vaginal mucosa. |
|
Medication includes 7.0-9.0 wt % of a dried thick fraction of a product of hazel dry sublimation, 0.025-0.033 wt % of hydrochloride anaprilin, 36.0-38.0 wt % of sodium hydrocarbonate, 24.5-25.5 wt % of boric acid, 12.0-16.0 wt % of phthalic acid, 5.5-7.5 wt % of sodium carboxymethylcellulose, 0.8-1.0 wt % of sodium dodecylsulphate, 0.45-0.55 wt % of calcium stearate and 5.5-10.8 wt % of glucose. |
|
|
Suppositories for treating hemorrhoid, proctitis and other proctologic inflammations Invention refers to an agent for treating hemorrhoid, proctitis and other proctologic inflammations. The above agent represents a suppository 1,35 - 3,65 g containing diosmin 0,3 - 0,65 g, dexpanthenol 0,05 - 0,2 g, green tea extract 0,05 - 0,2 g as active substances, and emulsifier 0,0135 - 0,1825 g and fatty acid glycerides as additives. |
|
|
Method of treating chronic pain syndrome Suppositories, containing uniformly distributed in one suppository recombinant human interferon-alpha-2b in an amount of 400000-600000 IU and immunoglobulins IgA, IgM and IgG in an amount of 0.1-0.3 g, are additionally rectally introduced as the second medication to an adult patient in case of the long-term introduction of an opioid-containing medication. The dose constitutes 2-3 suppositories 2-3 times per day with the reduction of the daily dose by 1-3 suppositories in case of the reduction of pain sensation to 2-3 points by a ten-point scale and expressed sedation. If pain sensation increases to 6-8 points by the ten-point visual analogue scale, the daily dose is increased by 1-3 suppositories. |
|
|
Intravaginal drug delivery system and method for making same Present invention refers to intravaginal drug delivery system the above system (5) comprises at least one portion (1a and 1b), comprising an inner portion (2) with a cross-section diameter d2 equal to 2-10 mm, and a membrane (3) covering the inner portion, wherein the inner portion and the membrane substantially consist of the same polymer structure or various polymer structures. Besides, the intravaginal drug delivery system comprises a connector (6) permeable for a therapeutically active substances with the cross-section diameter d6 equal to 0.5-4.0mm for forming the continuous working drug delivery system. The present invention also refers to a method for making the above intravaginal drug delivery system. |
|
Agent with glutaminic acid and propolis extract, having nootropic activity Agent contains the following per 1 suppository: 1.0 g glutaminic acid and 0.4 g of a 10% alcohol extract of propolis as active substances, as well as 2.0 g cacao oil, 0.15 g Cremophore CO-40 and 0.1 g PEG 400 as a base. |
|
Rectal suppositories with nicotinic acid and propolis extract Invention refers to the pharmaceutical industry, namely to an agent for treating haemorrhoid. The agent in the form of rectal suppositories for treating haemorrhoid containing 10% ethanolic extract of propolis, nicotinic acid, polyethylene glycol 1500 (PEG 1500), polyethylene glycol 4000 (PEG 4000), emulsifier T-2, Lutrol F68 and Cremophore CO-40 in certain proportions. |
|
Combination for correction of neurologic and psychoemotional status in case of organic cns disorders Invention represents pharmaceutical composition for correction and therapy of manifestations of amyloid intoxication in patients with brain pathologies, which are characterised by the fact that it contains melatonin 3-10 mg and memantine 5-300 mg. |
|
Antifungal therapeutic preparation in suppositories for children Invention represents an antifungal preparation in suppositories for children containing recombinant human interferon 2α and fluconazole, wherein lysozyme, Licopid and dimephosphone are additionally introduced. |
|
|
Medication against hiv/aids transmission through sexual contact Invention relates to medication against HIV/AIDS transmission through sexual contact and to method of HIV-infection prevention by introduction of said medication. Medication is made in form of suppository, which includes active substance and pharmacologically acceptable base. As active substance used is fraction of humic acids, extracted from oxidised brown coal, which possesses anti-HIV activity. As base used is cocoa butter or hard confectionery fat and emulsifier. Medication is introduced intravaginally 30 minutes before sexual intercourse. |
|
Method of treating skin and mucosal diseases caused by herpes simplex viruses type 1 and type 2 Invention refers to a method of treating recurrent skin and mucosal diseases caused by herpes simplex viruses type 1 and type 2 by coating a damaged region with a preparation containing a base including an active substance - (2,6-dichlorophenyl)amide carbopentoxysulphanic acid of the general formula: wherein X is Na, K, NH4, 2 times a day for 3-5 days, and if observing precursory symptoms, a repeated course of coating with the preparation is performed 1-2 times a day for 2-3 days. |
|
Treating-preventive mud composition Invention relates to the pharmaceutical industry, namely to a treating-preventive mud composition. The treating-preventive mud composition contains preliminarily prepared silt-clayey deposits of lake Tambukan, polyethyleneglycol 4000, polyethyleneglycol 1500, cremophor RH, as well as a carbon dioxide extract of propolis and/or a carbon dioxide vegetable extract, selected from the group, which includes, at least, eucalyptus, dog-rose, hop, laurel, chamomile, licorice and oak, taken in a specified ratio of components. |
|
|
Invention represents a drug preparation for treating diseases caused by type 1 herpes simplex and cytomegalovirus, containing recombinant human interferon 2α, lisocyme, Licopid, carnitine 20%, vitamin E and a fatty base. |
|
|
Present invention refers to a solid pharmaceutical product for oral administration which contains a photosensitiser representing a compound of general formula I: |
|
Suppositories comprise active substance triphenyl-(3,5-di-tret-butyl-4-hydroxybenzyl) phosphonium bromide in an amount of 1%. As the pharmaceutically acceptable carriers the suppositories comprise "polyethylene glycol-6000" (30%), higher fatty alcohols C16-C21 (0.6%), calcium stearate (0.8%) and sucrose (42.8%), foaming agents contain citric acid (10%), sodium bicarbonate (14.8%). |
|
Agent for preventing chronic fatigue syndrome in males Invention refers to pharmaceutical industry, namely to an agent for preventing chronic fatigue syndrome in males. The agent for preventing chronic fatigue syndrome in males is presented in the form of suppositories containing male red deer's blood plasma, dry sweetvetch extract, L-arginine and additives in certain proportions. |
|
|
There are presented: using nalbuphine salt in the form of a hydrophilic emulsion suppository for treating moderate to severe pain syndrome, a pharmaceutical composition for the same application in the form of suppositories comprising nalbuphine hydrochloride as an active substance and a hydrophilic emulsion base in the following ratio, g/100 g of the composition: nalbuphine hydrochloride 0.0125-5.00, hydrophilic emulsion base up to 100 g, and a method for preparing the same. |
|
Declared products are presented in the form of suppositories and contain a mechanically active amorphous or amorphocrystalline calcium gluconate as an active substance and additives as a base. One of the declared agents contains hard fat, paraffin, cacao butter and Lutrol F68 as a base in specific proportions. The other agent contains Witepsol W35, Witepsol H15, kollidon CL and Cremophore RH-40 as a base in specific proportions. |
|
|
Conjugate represents benzoate-hydrocodone that has the following structure: benzoate-hydrocodone (Bz-HC). Invention also pertains to the application of pharmaceutical compound for obtaining the drug for curing the patient with illness, disease or condition mediated by opioid binding to the opioid receptors of the patient. |
|
Combined antipyretic drug in form of rectal suppositories Invention relates to combined antipyretic drug in form of rectal suppositories. Drug contains paracetamol, dimedrol and papaverine hydrochloride as active components, and lipophilic suppository base Suppocire (Suppocire NA-15) as auxiliary substance, with the following component ratio in g per 1 suppository with 2.0 g weight: paracetamol 0.3-0.5; dimedrol 0.03-0.05; papaverine hydrochloride 0.03-0.05; Suppocire (Suppocire NA-15) - the remaining part (to 2.0 g). |
|
Herbal tea for treating adolescents with labile arterial hypertension Invention relates to medicine, particularly to pharmacology in cardiology, particularly to a herbal tea for treating adolescents with labile arterial hypertension. The herbal tea for treating the adolescents suffering stable arterial hypertension containing dried grinded herbal raw material: quinquelobate motherwort herb, origanum herb, Baikal skullcap roots, thin-leaved milkwort roots taken in certain proportions. |
|
|
Herbal tea for adolescents suffering stable arterial hypertension Invention refers to pharmacology in cardiology, particularly to a herbal tea for treating the adolescents suffering stable arterial hypertension. The herbal tea for treating the adolescents suffering stable arterial hypertension containing dried grinded herbal raw material: creeping thyme herb, Baical woundwort herb, rose hips, Siberian patrinia roots in certain proportions. |
|
|
Pharmaceutical composition for prevention and treatment of depressions Invention refers to a pharmaceutical composition for treating and/or preventing depressions. The pharmaceutical composition contains an active substance presented by a selective serotonin reuptake inhibitor (SSRI) specified in a group of fluoxetine, paroxetine, citalopram, escitalopram, sertraline, fluvoxamine differing by the fact that as an active substance, it additionally contains N-acetyl-5-methoxytryptamine (melatonin) in the following proportions, mg: selective serotonin reuptake inhibitor (SSRI) - 10-30 mg, melatonin - 3-8 mg. The pharmaceutical composition may be presented by a solid dosage form - a tablet, a film-coated tablet, a capsule, by a soft dosage form - a rectal suppository. |
|
|
Invention refers to medicine, namely producing herbal pharmaceutical preparations for treating cancerous diseases in gynaecology and andrology. The preparation for treating cancerous diseases in gynaecology and andrology contains in 1 suppository 2.0 g: ethanolic propolis extract 0.05-0.1 g; ethanolic poison hemlock extract 0.1-0.15 ml; fir essential oil 0.02-0.05 ml; melmot-berries essential oil 0.02-0.025 ml; tea tree essential oil 0.02-0.025 ml; manna gum essential oil 0.015-0.018 ml; ethanolic plumepoppy extract 0.1-0.15 ml; ethanolic potatoe sprout extract 0.1-0.15 ml; black caraway oil 0.015-0.02 ml; betulinol (powder) 0.025-0.05 g; base to 2.0 g. |
|
|
Method for preparing agent for treating proctological and gynecological diseases Invention refers to a method for producing pharmaceutical preparations for rectal and vaginal introduction for treating proctological and gynaecological diseases. What is presented is a method for producing an agent for treating proctological and gynaecological diseases on the basis of bee glue to be mixed with palm oil and an emulsifier with the prepared mixture constantly stirred on a water bath; then alcohol is distilled off; the prepared mixture is diluted with palm oil, cooled to temperature 35-36 degrees and added with aqueous-alcoholic extracts, essences and herbal powder extracts; thereafter the whole amount with the introduced ingredients is mixed up and poured with a dispenser into moulds 2 g made of food foil. The method is used to prepare rectal or vaginal suppositories. The suppositories are free from preserving agent and have shelf life one-two years at storage temperature 5-10 degrees Celsius. |
|
|
Invention refers to pharmacy and concerns a composition for inflammatory diseases of the female genital sphere. The presented suppositories contain a complex herbal extract, aerosil, emulsifier T2, cocoa butter in the following proportions, g in a suppository of 2 g. The solid complex herbal extract 0.25, Aerosil, 0.06, Emulsifier 0.02, cocoa butter 1.82. The complex herbal extract is prepared as follows: the ground herbal raw material containing cow clover blossom clusters, black elder blossom, thistle herb, nettle herb and purple Echinacea herb in 70% alcohol in equal proportion of alcohol: raw material 1:8. The material is soaked for 48 hours. The prepared total extract is condensed under vacuum to moisture 25% and mixed with a meal monger extract in proportions 8:2. The prepared total extract is condensed under vacuum to moisture 25% and mixed with a meal monger extract in proportions 8:2. |
|
|
Method of treating chronic infectious prostatitis Invention relates to field of medicine, namely to urology, and can be used for treatment of patients with chronic infectious prostatitis. For this purpose, suppositories, containing 0.75 g of dense extract of licorice root on hydrophilic base with polyethylene glycol 6000 and polyethylene glycol stearate are introduced intrarectally, in dose 1 suppository with weight 2.25 g 2 times per day, daily. Course of treatment constitutes 10 days. |
|
|
Invention refers to medicine, namely pediatrics, may be used for preventing influenza and acute respiratory infections in children suffering bronchial asthma. For this purpose, 5 days before the scheduled influenza vaccination, Viferon is introduced in a child's body through rectum in the form of suppositories twice a day in the morning and in the evening, one suppository in a single dose for children aged 4 to 7 years old 150000 ME, 7 to 16 years - 500000 ME, and the second stage involves introducing the inactivated influenza vaccine. |
|
Rectal suppositories for treatment of hemorrhoids, proctitis and other proctological diseases Invention relates to chemical-pharmaceutical industry and represents medication for treatment of hemorrhoids, proctitis and other inflammatory proctological diseases in form of rectal suppository, characterised by the fact that it contains as active substances Juglanex and Tycveolum, as auxiliary substances contains polyethylene glycol 1500 and emulsifier T2, components in medication are in specified ratio in grams per 1 suppository, with weight 2.6 g. |
|
|
Rectal suppositories with solid licorice extract Invention refers to pharmacy, namely technology of preparation of rectal suppositories. The suppositories with solid licorice extract consist of solid licorice extract 0.75 g on a hydrophilic base, polyethylene glycol 6000 1.25 g and polyethylene glycol polystear 0.25 g. |
|
|
Non-surgical method for integrated treatment of acute and chronic anal fissures Invention refers to medicine, namely coloproctology, and is applicable for non-surgical integrated treatment of acute and chronic anal fissures. For this purpose, anaerobic and aerobic flora is analysed. Then rectal suppositories of the following formulation are prescribed in mg per 1 suppositorium: antibacterial preparation 200-400 mg, bismuth 80-160 mg, titanium dioxide 80-160 mg, lidocaine hydrochloride monohydrate 8-16 mg, base (solid fat) 1236-2472 mg. As an antibacterial preparation, metronidazole or gentamycin are used win relation to the presence of anaerobic or aerobic flora as shown by the analysis. The suppositories are prescribed twice a day in the morning and in the evening for 7-14 days. The rectal introduction of the gentamycin suppositories is added with the daily rectal introduction of metronidazole gel for 7-14 days. Additionally, all the patients take detralex or venarus 500 mg 1 tablet twice a day for 60 days, as well as meloxicam 7.5 mg once a day for 7 days and no-spa 40 mg 1 tablet 2-3 times a day or duspatalin 200 mg 1 capsule twice a day for 7 days. |
|
|
Elton mud suppositories for gynaecological and urological diseases Invention refers to medicine, namely a dosage form presented as suppositories for gynaecological and urological diseases. The suppositories for gynaecological and urological diseases contain a lipid complex of Elton lake mud dehydrated to 20-35%, PEG-1500 base, a preparation of Tykveol and T2 emulsifier in certain proportions, wt %. |
|
|
Method for treatment of herpes hepatitis FIELD: medicine. SUBSTANCE: invention is referred to the area of medicine and can be used for treatment of herpes hepatitis in children. The antiviral drugs prescribed included acyclovir (zovirax), valtrex, Isoprinosine, immunomodulatory drugs viferon, licopid, amixin, as well as ursodeoxycholic acid drugs, phosphogliv and viferon. Three different treatment protocols are used depending on the age. Doses, regimen and duration of exposure are established by protocols. EFFECT: decreased terms of treatment; prevented development of complications; method can be used in out-patient setting. 3 ex |
|
|
Method of obtaining radon-containing concentrate and device for its realisation Invention relates to method of obtaining radon-containing concentrate, which lies in barbotage of pure radon or radon with carrier-gas through oil or fat during time necessary for saturation. In the process of barbotage constant volume of carrier-gas is preserved, which is achieved by return of carrier-gas after saturation back into radon source. Invention also relates to device for obtaining radon-containing concentrate, which consists of radon source connected to device for contacting - extractor or bubbler. |
|
Method of treating children with manifestation of lingering jaundice in neonatal period Invention relates to medicine and is intended for treatment of lingering versions of jaundice course in newborn babies. UDCA preparations are administered in dose 20-30 mg/kg per day, therapy is carried out for not less than 3 months. Viferon suppositories are administered rectally. Day dose is 50 thousand units/kg. Scheme of introduction is 10 days-daily, after that every second day from 3 to 9-12 months. Cytomegalovirus is suppressed with application of medication aciclovir-akri and its analogues zovirax, valtrex for 21-30 days. To suppress causing agents of mycoplasmosis, ureaplasmosis and chlamidiosis, preparations from group of macrolids rovamicin and sumamed are administered. Scheme is: rovamicin in dose 100 thousand units/kg for 7 days, after that, sumamed with a single dose 10 mg/kg once, according to discontinuous scheme 1 time per week, for 3 weeks. Additionally applied are medications, enhancing phagocytocis: licopid, polyoxydonium, solution of dimephosphone in age doses. |
|
|
Pharmaceutical composition for treating prostate diseases (versions) Invention refers to medicine, namely to peptide preparations for treating prostate diseases. The pharmaceutical composition (the first version) comprises 7-60 wt % of a bioregulatory peptide complex of bovine prostate containing water-soluble peptides 9 % more, and 40-93 wt % of a chelate zinc-arginine-glycin complex. The pharmaceutical composition in the form of suppositories (the second version) contains 0.015-0.130 g of the bioregulatory peptide complex of bovine prostate and 0.086-0.200 g of the chelate zinc-arginine-glycin complex as a bioactive compound in one fat-based suppository 2.7-2.9 g. |
|
Suppositories with bee moth larvae extract and bee-glue extract for treating gynecopathies Suppositories contain 5 % ethanolic extract of bee moth larvae, 5 % ethanolic extract of bee-glue, Lutrol F 68, polyethylene glycol 4000 and Cremophore RH-40 in the following proportions, g: 5 % ethanolic extract of bee moth larvae - 0.09; 5 % ethanolic extract of bee-glue - 0.09; Lutrol F 68 - 0.75; PEG 4000 - 1.0; Cremophore RH-40 - 1.25. |
|
|
Derinat suppositories to be used in medical practice For treating urogenital clamidiosis, cytomegalovirus, herpes simplex, Helicobacter pylori, polyethylene oxide 1500 and polyethylene oxide 400 are melted in the ratio 9:1; the liquid melt is added with a design amount of the preservative sodium chloride; further a design amount of sodium deoxyribonucleate is added in mixing. A melted paste is mould to prepare Derinat suppositories of 1.3-2.5 g. |
|
|
Pharmaceutical composition for treating diseases of lower part of genitourinary system Invention relates to pharmacology and medicine and represents pharmaceutical composition for treating diseases of lower part of genitourinary system in form of suppositories, which includes bioactive compound and fat basis, characterised by the fact that as bioactive compound, composition contains mixture of amino acids: glutamic acid, lysine, alanine, arginine and glycine, and additionally zinc in form of zinc chloride, components in composition being in specified ratio per one suppository with weight 2.7-2.9 g. |
|
|
Invention relates to field of chemical-pharmaceutical industry, namely to novel anti-tuberculosis medication. Claimed medication contains as active substance 4-thioureidoiminomethyperidinium perchlorate in effective and safe quantity and pharmaceutically acceptable auxiliary substances. Also claimed is method of its obtaining, which makes it possible to obtain target product with high yield. Novel medication, obtained by claimed method, possesses high tuberculostatic activity and low toxicity, preserves its stability in long-term storage. |
|
Method of treating nonspecific aerobic vaginitis Claimed is method of treating nonspecific aerobic vaginitis by vagina sanitation with medication "Bioprost" in dose 1 suppository per night for 10 days. Method ensures complex therapeutic effect due to anti-inflammatory action of pumpkin seed oil, improving vigaina microecology, and thymol, which suppresses development of Gram-positive, Gram-negative bacteria, fungi, and possesses activity with respect to protozoa and herpes virus. |
|
|
Suppositories for treating proctologic and gynecologic diseases Invention refers to suppositories for treating proctologic and gynaecologic diseases. Said suppositories contain a drug in the form of the dehydrated preparation 'Baliz' or a power-predried form of the preparation 'Baliz', or an active substance pre-recovered from the preparation 'Baliz' in the form of comenic acid or its salts, and also a base representing fatty substances, and a food or medicinal emulsifier. |
|
|
Pharmaceutical composition containing hyaluronidase and liposomes for external application Invention refers to pharmacy, namely to a pharmaceutical composition for local application, containing enzyme hyaluronidase which can be used in pharmacy for treatment and prevention of inflammatory prostate diseases, such as prostatitis. The pharmaceutical composition for local application contains as an active ingredient hyaluronidase 2.44 wt %, Tween-80 2.93 wt %, PEG-1500 91.69 wt %, liposome 2.44 wt %, and pharmaceutically acceptable carriers or excipients, such as benzydamine 0.5 wt %. |
|
|
Immunocorrective agent for treating diseases of viral aetiology Invention refers to pharmacology and medicine. Substance of the invention consists that an immunocorrective drug exhibiting an intense specific antiviral activity for treating diseases of viral aetiology contains human recombinant interferon alpha and/or beta, and/or gamma, an antioxidant complex of tocopherol acetate or its derivative, including water-soluble ones, and ascorbic acid salts, calcium pantothenate, antiviral ingredients, as well as pharmaceutical aids and excipients in certain ratios in 1 g of the drug. As antiviral ingredients, the drug contains arbidol and its derivatives, remantadin, oseltamivir, ribavirin, inosine pranobex (isoprinosine), glycyrrhizic acid and its derivatives, nucleosides of a group - famvir, valacyclovir, ganciclovir, valganciclovir, foscarnet, cidofovir, lobucavir, sorivudine, brivudine, antiretroviral - lamivudine, zidovudine, lopinavir, stavudine. The agent is presented in rectal and vaginal suppositories, gel, ointment, liquid. |
|
|
Drug preparation tilorone in suppositories Invention refers to a pharmaceutical industry, and concerns making a preparation Tilorone in the form of rectal suppositories 125 mg, being an antiviral immunostimulant. |
|
|
Food additive for supply of nutritional mineral substances Food additive characterised by the minerals it contains being a component of a salt hydrate melt in the form of ions, the said nutrient substances represented by at least calcium; the salt hydrates melt is amorphously hardening and is represented by a salt-water system with water content in the food additive corresponding to the most hydrated ion coordination number. The food additive is used as admixture during production of food products, chewing gum, beverages, toothpaste, mouth wash liquids and oral cavity hygiene products. The nutrient mineral substances are easily digestible due to their containment in the additive in ion form. |
|
Method of treating chronic prostatitis Invention refers to medicine, namely to urology, and can be used for treating chronic bacterial non-Chlamidia prostatitis. That is ensured by the integrated treatment that involves antibacterial therapy and administration of Interferon A in the form of ointments or suppositories. The therapeutic course is 7 days to be repeated in a week. |
|
|
Application of octenidine dihydrochloride in semisolid preparations There is offered application of octenidine dihydrochloride for making a semisolid pharmaceutical compositions for wound repair, treatment of atopic dermatitis, infected eczema, dermatomycosis, vaginal infections, acne, herpes and/or control of pathogenic germs resistant to many medicinal preparations where the composition contains 0.005 to 5 wt % of octenidine dihydrochloride, propylene glycol, hydroxypropyl cellulose and water. |
|
Homoeopathic suppositories for treating genital disorders Invention refers to pharmaceutical industry, particularly to homoeopathic suppositories. Homoeopathic suppositories contain black walnut oil, walnut oil, homoeopathic oily extract of sea-buckthorn, melilot herb, sage herb, acacia blossom taken in equal portion, homoeopathic essence of black walnut, oily extract of Peloid mud of the Tambukan lake and a base taken in a certain ratio. |
Another patent 2550866.